Table 7 Logistic regression model to predict TOAST subtype of acute ischemic stroke in relation of prevalence of HLA allele and of HLA-KIR interactions

 HLA-A-Bw4

1.04

2.853

0.86–9.39

0.08

 HLA-C1

− 1.24

0.28

0.07–1.15

0.07

 HLA-C2

− 0.29

0.74

0.21–2.61

0.65

 HLA-B-Bw4^T

− 0.82

0.43

0.11–1.73

0.23

 HLA-B-Bw4^I

− 1.132

0.32

0.03–3.15

0.33

 2DL2-HLA-C1

− 0.50

0.60

0.16–2.19

0.44

 2DL3-HLA-C1

− 0.64

0.52

0.17–1.57

0.25

 2DS2-HLA-C1

0.49

1.647

0.59–4.57

0.33

 2DS-2HLA-C2

0.76

2.156

0.67–6.85

0.19

 2DL2-HLA-C2

0.06

1.063

0.31–3.56

0.92

 2DS1-HLA-C2

− 0.73

0.48

0.08–2.86

0.42

 2DL1-HLA-C1

0.18

1.197

0.28–4.96

0.80

 2DL1-HLA-C2

− 0.24

0.78

0.17–3.49

0.75

 aplotipoHLA-A

− 0.38

0.68

0.25–1.79

0.44

 HLA-A-Bw4

− 1.322

0.26

0.07–1.01

0.05

 AB haplotype

− 0.13

0.87

0.27–2.8

0.82

 HLA-C1

0.31

1.37

0.29–6.36

0.68

 HLA-C2

− 0.46

0.62

0.14–2.66

0.52

 HLA-B-Bw4^T

1.006

2.73

0.59–12.53

0.19

 HLA-B-Bw4^I

0.87

2.4

0.19–30.19

0.49

 2DL2-HLA-C1

0.10

1.1

0.26–4.66

0.89

 2DL3-HLA-C1

0.48

1.63

0.47–5.60

0.43

 2DS-2HLA-C1

− 0.89

0.4

0.12–1.33

0.13

 2DS2-HLA-C2

− 1.35

2.58

0.06–1.03

0.05

 2DL2-HLA-C2

− 0.12

0.88

0.22–3.41

0.85

 2DS1-HLA-C2

0.79

2.2

0.31–15.67

0.43

 2DL1-HLA-C1

− 1.46

0.23

0.03–1.64

0.14

 2DL1-HLA-C2

− 0.01

0.98

0.19–5.03

0.98

 HLA-A-Bw4

− 0.48

0.61

0.15–2.40

0.48

 AB-haplotype

− 1.18

0.3

0.08–1.15

0.08

 HLA-C1

2.36

10.63

2.10–53.78

0.004

 HLA-C2

1.24

3.48

0.71–17.07

0.12

 HLA-B-Bw4^T

0.96

2.63

0.51–13.38

0.24

 HLAB-B-w4^I

2.135

8.45

0.71–100.69

0.09

 2DL2-HLA-C1

0.64

1.91

0.43–8.33

0.38

 2DL3-HLA-C1

0.67

1.96

0.52–7.29

0.31

 2DS2-HLA-C1

0.26

1.3

0.37–4.56

0.67

 2DS2-HLA-C2

− 0.05

0.95

0.21–4.14

0.94

 2DL2-HLA-C2

− 0.29

0.74

0.18–3.05

0.68

 2DS1-HLA-C2

0.68

1.97

0.27–14.06

0.49

 2DL1-HLA-C1

0.60

1.82

0.40–8.31

0.43

 2DL1-HLA-C2

0.78

2.19

0.39–12.19

0.36